Question 1

What is LOPJLB’s current signal on ELTX?

Accepted Answer

LOPJLB’s latest quantitative signal on Elicio Therapeutics, Inc. (ELTX) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is ELTX in?

Accepted Answer

Elicio Therapeutics, Inc. (ELTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does Elicio Therapeutics, Inc. (ELTX) do?

Accepted Answer

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG …

Question 4

Where is Elicio Therapeutics, Inc. based / listed?

Accepted Answer

Elicio Therapeutics, Inc. is based in US, listed on NASDAQ.

Elicio Therapeutics, Inc. (ELTX)

Key stats

Prediction markets

Company news